Abstract
2526Background: Oraxol is an oral formulation of paclitaxel (PTX) co-administered with the potent, selective, poorly absorbed, P-glycoprotein inhibitor HM30181A (HM) that enhances the absorption of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
